Eterna raises $3.9M via 12% notes; proposes debt/warrant exchange for 38.3M shares

Ernexa Therapeutics Inc.

Closed $3.9M 12.0% senior convertible note private placement; net proceeds for general corporate purposes.
Agreed to sell 1,516,997 shares at $0.75/share for $1.1M in a separate common stock private placement.
Proposes to exchange outstanding convertible notes and warrants for ~38.3M shares, subject to stockholder approval.
Annual meeting postponed from Sept 27 to Oct 29, 2024; stockholder proposals due Oct 5.
Support agreements covering ~48% of outstanding shares commit to vote in favor of stockholder approval.

item 1.01 item 2.03 item 3.02 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.